Atlas Trials

Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

Clinical trial NCT06472713 · RECRUITING

Trial details

NCT number
NCT06472713
Sponsor
Ming-Yuan Chen
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Nasopharyngeal Carcinoma
Start date
2024-07-20
Primary completion
2025-10-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.